What is the equivalent dosage of clonazepam for a 5mg dose of Xanax (alprazolam) in an adult patient with a history of anxiety or panic disorders?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Benzodiazepine Dose Conversion: Alprazolam to Clonazepam

There is no standard 5mg dose of alprazolam (Xanax)—the maximum FDA-approved dose is 4mg daily for panic disorder, and 5mg would be considered excessive and potentially dangerous. However, if converting a theoretical 5mg alprazolam dose to clonazepam, the equivalent would be approximately 2.5mg clonazepam based on the established 2:1 conversion ratio.

Standard Conversion Ratio

The established conversion ratio between alprazolam and clonazepam is approximately 2:1, meaning 1mg of clonazepam equals roughly 2mg of alprazolam. 1

  • Using this ratio, 5mg alprazolam would convert to approximately 2.5mg clonazepam 1
  • This conversion applies most reliably for anxiolysis, sedation, and acute agitation management 1

Critical Safety Concerns with This Dose

A 5mg alprazolam dose significantly exceeds standard therapeutic ranges and raises serious safety concerns:

  • The maximum recommended dose for panic disorder with alprazolam is 4mg daily, typically divided into multiple doses 2
  • Alprazolam requires t.i.d. or q.i.d. dosing due to its shorter half-life, leading to interdose anxiety and rebound symptoms 3
  • Patients on such high doses are at substantial risk for respiratory depression, especially when combined with other CNS depressants or opioids 1

Advantages of Switching to Clonazepam

Clonazepam offers significant clinical advantages over alprazolam, particularly at higher doses:

  • Clonazepam has a dramatically longer half-life (30-40 hours) compared to alprazolam, allowing for once or twice daily dosing and eliminating interdose anxiety 1, 3
  • In a clinical study of 48 panic disorder patients switched from alprazolam to clonazepam, 82% rated clonazepam as "better" due to decreased dosing frequency and lack of interdose anxiety 3
  • Clonazepam can be considered a first-line agent for panic disorder with several advantages over other benzodiazepines 4

Practical Conversion Protocol

When converting from high-dose alprazolam to clonazepam:

  • Start clonazepam at 2-2.5mg daily (divided into 2 doses initially) while gradually tapering alprazolam 1, 4
  • Reduce alprazolam by 0.5mg every 3-5 days while maintaining stable clonazepam dosing 5
  • Monitor closely for withdrawal symptoms including anxiety, tremor, insomnia, and autonomic hyperactivity 5

Monitoring Requirements and Precautions

Critical monitoring parameters during and after conversion:

  • Monitor for morning sedation, early morning motor incoordination, confusion, memory dysfunction, and fall risk—all more common with clonazepam's long half-life 1
  • Use particular caution in patients with obstructive sleep apnea, neurodegenerative disorders, or liver disease 1
  • Monitor oxygen saturation and be prepared to provide respiratory support, especially during the conversion period when both medications may overlap 1
  • Women may require higher doses than men to achieve the same clinical effect 1

Long-Term Considerations

For patients requiring chronic benzodiazepine therapy:

  • Clonazepam exhibits a prophylactic effect against recurrence of depression when used long-term at lower doses 6
  • Therapeutic doses for panic disorder typically range from 1-4mg daily, with most patients responding to 2-3mg daily 4
  • If discontinuation is desired after long-term use, taper by 0.25mg per week after reaching 1mg daily to minimize withdrawal symptoms 5

References

Guideline

Benzodiazepine Dose Equivalency

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

High-potency benzodiazepines: recent clinical results.

The Journal of clinical psychiatry, 2004

Research

Use of benzodiazepines in panic disorder.

The Journal of clinical psychiatry, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.